Crude odds ratios for subgroups
| . | Above 90th percentile (> 129 U/dL) . | Below 90th percentile (≤ 129 U/dL) . | Odds ratio (95% CI) . |
|---|---|---|---|
| All (n = 899) | |||
| Patients | 86 | 340 | 2.3 (1.6-3.5) |
| Controls | 46 | 427 | |
| Sex | |||
| Men (n = 373) | |||
| Patients | 29 | 143 | 1.9 (1.0-3.6) |
| Controls | 19 | 182 | |
| Women (all) (n = 526) | |||
| Patients | 57 | 197 | 2.6 (1.6-4.3) |
| Controls | 27 | 245 | |
| Use of oral contraceptives* | |||
| Yes (premenopausal) (n = 77) | |||
| Patients | 10 | 20 | 1.5 (0.5-4.0) |
| Controls | 12 | 35 | |
| No (premenopausal) (n = 130) | |||
| Patients | 12 | 28 | 12.4 (3.3-47.2) |
| Controls | 3 | 87 | |
| No (postmenopausal) (n = 148) | |||
| Patients | 21 | 39 | 6.2 (2.4-15.9) |
| Controls | 7 | 81 | |
| Age (y) | |||
| < 45 (n = 453) | |||
| Patients | 37 | 180 | 2.5 (1.4-4.5) |
| Controls | 18 | 218 | |
| ≥ 45 (n = 446) | |||
| Patients | 49 | 160 | 2.3 (1.4-3.8) |
| Controls | 28 | 209 |
| . | Above 90th percentile (> 129 U/dL) . | Below 90th percentile (≤ 129 U/dL) . | Odds ratio (95% CI) . |
|---|---|---|---|
| All (n = 899) | |||
| Patients | 86 | 340 | 2.3 (1.6-3.5) |
| Controls | 46 | 427 | |
| Sex | |||
| Men (n = 373) | |||
| Patients | 29 | 143 | 1.9 (1.0-3.6) |
| Controls | 19 | 182 | |
| Women (all) (n = 526) | |||
| Patients | 57 | 197 | 2.6 (1.6-4.3) |
| Controls | 27 | 245 | |
| Use of oral contraceptives* | |||
| Yes (premenopausal) (n = 77) | |||
| Patients | 10 | 20 | 1.5 (0.5-4.0) |
| Controls | 12 | 35 | |
| No (premenopausal) (n = 130) | |||
| Patients | 12 | 28 | 12.4 (3.3-47.2) |
| Controls | 3 | 87 | |
| No (postmenopausal) (n = 148) | |||
| Patients | 21 | 39 | 6.2 (2.4-15.9) |
| Controls | 7 | 81 | |
| Age (y) | |||
| < 45 (n = 453) | |||
| Patients | 37 | 180 | 2.5 (1.4-4.5) |
| Controls | 18 | 218 | |
| ≥ 45 (n = 446) | |||
| Patients | 49 | 160 | 2.3 (1.4-3.8) |
| Controls | 28 | 209 |
At time of thrombosis (or similar index date for controls) as well as at time of venipuncture (16 of the 153 premenopausal women mentioned earlier changed their oral contraceptive use and were therefore excluded from this analysis).